Episurf Medical and Xbrane Biopharma invites to a company presentation held at Episurf Medical’s office at Karlavägen 60 in Stockholm on May 29, 18.00-20.30 CEST.
Episurf Medical will be represented by CEO Pål Ryfors and Xbrane Biopharma by CEO Martin Åmark. The presentation will be broadcasted via Finwire.
A light meal will be served during the evening.
For more information, please contact:
Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
About Episurf Medical
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalised treatment alternatives. Episurf Medical’s Episealer® personalised implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.